AXON:NYE-Axovant Sciences Ltd. (USD)

EQUITY | Aerospace & Defense | New York Stock Exchange

Last Closing

USD 595.18

Change

-20.96 (-3.40)%

Market Cap

USD 1.28B

Volume

1.39M

Analyst Target

USD 4.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Axovant Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-12 )

Largest Industry Peers for Aerospace & Defense

Symbol Name Price(Change) Market Cap
ESLT Elbit Systems Ltd

-2.93 (-1.21%)

USD 10.27B
WWD Woodward Inc

+0.48 (+0.27%)

USD 9.62B
AVAV AeroVironment Inc

-0.47 (-0.22%)

USD 6.14B
RKLB Rocket Lab USA Inc.

+4.17 (+28.44%)

USD 5.67B
KTOS Kratos Defense & Security Solu..

+0.47 (+1.72%)

USD 3.45B
VSEC VSE Corporation

+0.20 (+0.17%)

USD 2.09B
MRCY Mercury Systems Inc

-0.37 (-0.85%)

USD 1.97B
EH Ehang Holdings Ltd

+1.54 (+9.72%)

USD 1.05B
ATRO Astronics Corporation

-0.37 (-2.19%)

USD 0.61B
SWBI Smith & Wesson Brands Inc

-0.20 (-1.51%)

USD 0.59B

ETFs Containing AXON

GUNZ 6.17 % 0.00 %

N/A

N/A
XAR SPDR® S&P Aerospace & De.. 5.41 % 0.35 %

+2.17 (+0%)

USD 2.58B
XAD:CA iShares U.S. Aerospace & .. 4.42 % 0.00 %

+0.64 (+0%)

N/A
QQQN VictoryShares Nasdaq Next.. 3.25 % 0.00 %

N/A

USD 0.02B
EQJS:LSE Invesco NASDAQ Next Gener.. 2.21 % 0.00 %

+6.75 (+0%)

USD 0.05B
SAGP The Advisorsa Inner Circl.. 2.16 % 0.00 %

-0.12 (0%)

USD 0.04B
QQQJ Invesco NASDAQ Next Gen 1.. 2.16 % 0.00 %

-0.18 (0%)

USD 0.63B
EQQJ:XETRA Invesco NASDAQ Next Gener.. 1.96 % 0.00 %

+0.25 (+0%)

USD 0.05B
MMSC First Trust Multi-Manager.. 1.89 % 0.00 %

-0.15 (0%)

USD 0.02B
TMFX Motley Fool Next Index ET.. 1.80 % 0.00 %

-0.01 (0%)

USD 0.03B
IQCT:LSE Amundi Index Solutions - .. 1.79 % 0.00 %

+0.29 (+0%)

USD 0.08B
EQQJ:LSE Invesco NASDAQ Next Gener.. 1.55 % 0.00 %

+0.28 (+0%)

N/A
AMEC:XETRA Amundi Index Solutions - .. 1.54 % 0.00 %

+0.54 (+0%)

USD 9.60M
SCITY:PA 1.54 % 0.00 %

N/A

N/A
SCITY:SW Amundi Index Solutions - .. 1.54 % 0.00 %

N/A

USD 0.07B
RSPN Invesco S&P 500® Equal.. 1.43 % 0.00 %

+0.06 (+0%)

USD 0.64B
QWST 1.36 % 0.00 %

N/A

N/A
FXR First Trust Industrials/P.. 1.32 % 0.62 %

N/A

USD 1.99B
IQCY:LSE Amundi Index Solutions - .. 1.25 % 0.00 %

+0.36 (+0%)

N/A
VBK Vanguard Small-Cap Growth.. 1.08 % 0.07 %

-1.65 (0%)

USD 19.73B
JOET Virtus ETF Trust II 1.03 % 0.00 %

-0.03 (0%)

USD 0.12B
IUSF:LSE iShares IV Public Limited.. 0.43 % 0.00 %

+5.88 (+0%)

USD 0.29B
IUSZ:LSE iShares Edge MSCI USA Siz.. 0.43 % 0.00 %

+0.05 (+0%)

USD 0.29B
JPSC:XETRA JPMorgan BetaBuilders US .. 0.41 % 0.00 %

+0.08 (+0%)

N/A
QDVC:XETRA iShares Edge MSCI USA Siz.. 0.39 % 0.00 %

+0.08 (+0%)

USD 0.19B
IUSZ:SW iShares Edge MSCI USA Siz.. 0.39 % 0.00 %

N/A

N/A
IWFS:LSE iShares MSCI World Size F.. 0.18 % 0.00 %

+4.00 (+0%)

USD 0.28B
IWSZ:LSE iShares IV Public Limited.. 0.18 % 0.00 %

-0.02 (0%)

USD 0.28B
CHEP 0.00 % 1.12 %

N/A

N/A
FAD First Trust Multi Cap Gro.. 0.00 % 0.69 %

-0.88 (0%)

USD 0.22B
FEX First Trust Large Cap Cor.. 0.00 % 0.61 %

+0.01 (+0%)

USD 1.28B
FTC First Trust Large Cap Gro.. 0.00 % 0.61 %

-0.03 (0%)

USD 1.10B
ITA 0.00 % 0.42 %

N/A

N/A
SCHM Schwab U.S. Mid-Cap ETF 0.00 % 0.05 %

-0.09 (0%)

N/A
VB Vanguard Small-Cap Index .. 0.00 % 0.05 %

-1.20 (0%)

N/A
DFEN Direxion Daily Aerospace .. 0.00 % 1.09 %

+0.51 (+0%)

USD 0.19B
BFTR 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Aerospace & Defense) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 130.40% 88% B+ 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 130.40% 88% B+ 96% N/A
Trailing 12 Months  
Capital Gain 168.61% 88% B+ 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 168.61% 88% B+ 95% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 25.38% 67% D+ 78% C+
Dividend Return 25.38% 67% D+ 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 43.16% 39% F 43% F
Risk Adjusted Return 58.81% 85% B 83% B
Market Capitalization 1.28B 100% F 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Aerospace & Defense) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 158.80 14% 8%
Price/Book Ratio 22.18 8% 6%
Price / Cash Flow Ratio 248.25 7% 1%
Price/Free Cash Flow Ratio 279.38 4% 1%
Management Effectiveness  
Return on Equity 16.42% 96% 87%
Return on Invested Capital 8.22% 81% 74%
Return on Assets 2.29% 71% 75%
Debt to Equity Ratio 42.00% 21% 46%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.